Newfoundland Starter Care Guide

About the Newfoundland

Cornell identifies a recessive SLC3A1 variant associated with Type I cystinuria in Newfoundlands, meaning two copies are needed for genetic at-risk status. Clinical disease still depends on cystine accumulation and stone formation, which require veterinary urine testing and imaging rather than DNA status alone.

Breed traits are general patterns, not promises. Individual health, temperament, age, home and life experience still matter more than the label.

Health areas to know for Newfoundland

The source below highlights hip and elbow dysplasia, heart disease, and cystinuria in its breed health-testing guidance. For owners, these are areas to understand and discuss with a veterinarian—not a prediction that this dog is affected, not a complete list of breed risks and not breeding advice.

Ask the veterinarian which source-listed areas matter for this dog's age, history and current health, what changes to watch for and which signs would need a prompt call.

Save any existing result with the named condition or body system, test or examination, date and exact finding so one result is never treated as a whole-dog clearance.

Record new or worsening symptoms with timing, context and a photo or video when safe, then seek veterinary assessment instead of assigning the change to breed alone.

Important limit: The linked source was created to guide breed health testing, often in breeding programs. It does not show how likely an individual pet is to develop a condition, create a personal testing schedule or replace diagnosis; some results describe carrier or risk status rather than current disease.